PLOD2 Monoclonal antibody 66342-1-Ig proteintech

$149.00
In stock
SKU
66342-1-Ig
Catalog No.SizePrice (USD)
66342-1-IG-20UL20 μL$149.00
66342-1-IG-150UL150 μL$449.00
66342-1-IG-10X150UL1.5 mL (10 x 150 μL vials)$3,592.00
Catalog Number66342-1-Ig
Synonyms1H9E1, EC:1.14.11.4, Lysyl hydroxylase 2, PLOD2/LH2, Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2
HostMouse
Reactivityhuman, mouse, rat
FormLiquid
FormulationPBS, Azide, Glycerol
ApplicationsWB, IHC, IF, ELISA
ApplicationsWB, IHC, ELISA
Host / IsotypeMouse / IgA
Tested Applications — Positive WB detected inDU 145 cells, A431 cells, HEK-293 cells, THLE-2 cells, A549 cells, Hela cells, HEK293 cells, HepG2 cells, HSC-T6 cells, NIH/3T3 cells, 4T1 cells
Tested Applications — Positive IHC detected inhuman liver cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Recommended Dilutions — Western Blot (WB)WB : 1:1000-1:4000
Recommended Dilutions — Immunohistochemistry (IHC)IHC : 1:200-1:1000
Positive WB detected inDU 145 cells, A431 cells, HEK-293 cells, THLE-2 cells, A549 cells, Hela cells, HEK293 cells, HepG2 cells, HSC-T6 cells, NIH/3T3 cells, 4T1 cells
Positive IHC detected inhuman liver cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Western Blot (WB)WB : 1:1000-1:4000
Immunohistochemistry (IHC)IHC : 1:200-1:1000
Tested Reactivityhuman, mouse, rat
Cited Reactivityhuman
ClassMonoclonal
TypeAntibody
ImmunogenCatNo: Ag5779 Product name: Recombinant human PLOD2 protein Source: e coli. -derived, PET28a Tag: 6*His Domain: 410-758 aa of BC037169 Sequence: NRKIIAPLVTRHGKLWSNFWGALSPDGYYARSEDYVDIVQGNRVGVWNVPYMANVYLIKGKTLRSEMNERNYFVRDKLDPDMALCRNAREMTLQREKDSPTPETFQMLSPPKGVFMYISNRHEFGRLLSTANYNTSHYNNDLWQIFENPVDWKEKYINRDYSKIFTENIVEQPCPDVFWFPIFSEKACDELVEEMEHYGKWSGGKHHDSRISGGYENVPTDDIHMKQVDLENVWLHFIREFIAPVTLKVFAGYYTKGFALLNFVVKYSPERQRSLRPHHDASTFTINIALNNVGEDFQGGGCKFLRYNCSIESPRKGWSFMHPGRLTHLHEGLPVKNGTRYIAVSFIDP Predict reactive species
Full Nameprocollagen-lysine, 2-oxoglutarate 5-dioxygenase 2
Calculated Molecular Weight758 aa, 85 kDa
Observed Molecular Weight87 kDa
GenBank Accession NumberBC037169
Gene SymbolPLOD2
Gene ID (NCBI)5352
RRIDAB_2881722
ConjugateUnconjugated
Purification MethodThiophilic affinity chromatograph
UNIPROT IDO00469
Storage BufferPBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA.
IHC protocol for PLOD2 antibody 66342-1-IgDownload protocol
WB protocol for PLOD2 antibody 66342-1-IgDownload protocol
humanIHC Aging (Albany NY) Systematic characterization of the expression, prognosis and immune characteristics of PLOD family genes in breast cancer Authors - Dan-Dan Wang View Article
Citations12
DilutionsWB : 1:1000-1:4000 IHC : 1:200-1:1000
IsotypeIgA
ClonalityMonoclonal
Clone Number1H9E1
ConjugationUnconjugated

PLOD2,also named as LH2, forms hydroxylysine residues in -Xaa-Lys-Gly- sequences in collagens. It is a potential novel prognostic factor for HCC patients following surgery. Among the PLOD genes, PLOD2 contributes to cancer prognosis and angiogenesis. Several authors have reported that PLOD2 expression might provide prognostic information about malignant tumours such as glioblastoma. PLOD2 expression is a useful biomarker for the effects of antiangiogenic treatment for malignancy.(PMID:22098155). It has 2 isoforms produced by alternative splicing and seven glycosylation sites. Protocols Product Specific Protocols IHC protocol for PLOD2 antibody 66342-1-Ig Download protocol WB protocol for PLOD2 antibody 66342-1-Ig Download protocol Standard Protocols Click here to view our Standard Protocols

Publications

  1. Identification and Validation of a Nine-Gene Amino Acid Metabolism-Related Risk Signature in HCC.
    Journal: Front Cell Dev Biol | Authors: Yajuan Zhao | Species: human | Application: WB,IHC
  2. CKAP4 and PLOD2 as novel prognostic biomarkers in hepatocellular carcinoma: a proteomics-driven risk stratification model
    Journal: Front Cell Dev Biol | Authors: Qiulong Lu | Species: human | Application: IHC
  3. Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation
    Journal: Cell Death Dis | Authors: Tao Liu KD Validated | Species: human | Application: WB,IHC
  4. FAP+ fibroblasts orchestrate tumor microenvironment remodeling in renal cell carcinoma with tumor thrombus
    Journal: Nat Commun | Authors: Jiacheng Ma | Species: human | Application: IF
  5. Targeting RORγ inhibits the growth and metastasis of hepatocellular carcinoma
    Journal: Mol Ther | Authors: Qianqian Liu | Species: human | Application: WB
  6. Systematic characterization of the expression, prognosis and immune characteristics of PLOD family genes in breast cancer
    Journal: Aging (Albany NY) | Authors: Dan-Dan Wang | Species: human | Application: IHC
  7. CKAP4 and PLOD2 as novel prognostic biomarkers in hepatocellular carcinoma: a proteomics-driven risk stratification model
    Journal: Front Cell Dev Biol | Authors: Qiulong Lu | Species: human | Application: IHC
  8. Identification and Validation of a Nine-Gene Amino Acid Metabolism-Related Risk Signature in HCC.
    Journal: Front Cell Dev Biol | Authors: Yajuan Zhao | Species: human | Application: WB,IHC
  9. Cancer-Associated Fibroblast-Centric Risk Model Predicts Immunotherapy Resistance in Pancreatic Cancer and Reveals PLOD2 as a Key Stromal Therapeutic Target.
    Journal: Front Biosci (Landmark Ed) | Authors: Pengwei Cao | Species: human | Application: WB
  10. Prognostic biomarker and clinical significance of PLOD gene family in clear cell renal cell carcinoma.
    Journal: Front Oncol | Authors: Xuan Shang | Species: human | Application: WB
  11. Hypoxia-Driven Immune Escape in Clear Cell Renal Cell Carcinoma: A Prognostic Model and Dual-Functional Biomarker PLOD2 for Immunotherapy Stratification.
    Journal: J Cancer | Authors: Fei Xiao | Species: human | Application: IHC,IF
  12. Systematic characterization of the expression, prognosis and immune characteristics of PLOD family genes in breast cancer
    Journal: Aging (Albany NY) | Authors: Dan-Dan Wang | Species: human | Application: IHC

Product Documents

Datasheet

Datasheet

Reviews

Write Your Own Review
You're reviewing:PLOD2 Monoclonal antibody 66342-1-Ig proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.